Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.
Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) is associated with clinical treatment failure. However, the resistance mechanism of hVISA has not been fully clarified. In the present study, comparative proteomics analysis of two pairs of isogenic vancomycin-susceptible S. aureus...
Main Authors: | Hongbin Chen, Yali Liu, Chunjiang Zhao, Di Xiao, Jianzhong Zhang, Feifei Zhang, Minjun Chen, Hui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3696005?pdf=render |
Similar Items
-
Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus
by: Fred C. Tenover, et al.
Published: (2001-04-01) -
Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.
by: Shanshan Zhang, et al.
Published: (2015-01-01) -
Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus aureus Strains
by: Ye Jin, et al.
Published: (2020-10-01) -
Molecular features of heterogeneous vancomycin-intermediate <it>Staphylococcus aureus </it>strains isolated from bacteremic patients
by: Belausov Natasha, et al.
Published: (2009-09-01) -
Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection etest and population analysis profiling
by: Siti Roszilawati Ramli, et al.
Published: (2012-03-01)